Syndax Pharmaceuticals
SNDX
SNDX
97 hedge funds and large institutions have $484M invested in Syndax Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 47 increasing their positions, 13 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
21.76% more ownership
Funds ownership: 68.68% → 90.44% (+22%)
17% more funds holding
Funds holding: 83 → 97 (+14)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
97
Holding in Top 10
2
Calls
$13.1M
Puts
$2.79M
Top Buyers
| 1 | +$23.1M | |
| 2 | +$22.6M | |
| 3 | +$15.2M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$15.2M |
| 5 |
O
OrbiMed
New York
|
+$11.9M |
Top Sellers
| 1 | -$5.82M | |
| 2 | -$3.94M | |
| 3 | -$963K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$891K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$867K |